Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments
Sepsis frequently leads to multiple organ failure and is a major cause of morbidity and mortality in critically ill patients. Although intensive care protocols and antibiotic therapy have improved sepsis treatment, specific management is lacking with respect to efficient protection from tissue damag...
Main Authors: | Vinicios R. dos Santos, Gabriela O. de Carvalho, José Bruno N. F. Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Microbiology Research |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7481/12/3/39 |
Similar Items
-
Construction Methods and Influencing Factors on Animal Model of Sepsis
by: LI Xiao, et al.
Published: (2022-06-01) -
The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model
by: Duc Tin Tran, et al.
Published: (2020-11-01) -
Aloe-Emodin Ameliorates Cecal Ligation and Puncture-Induced Sepsis
by: Jingqian Su, et al.
Published: (2023-07-01) -
Fucoxanthin Ameliorates Sepsis via Modulating Microbiota by Targeting IRF3 Activation
by: Jingqian Su, et al.
Published: (2023-09-01) -
Protective effects of oridonin on the sepsis in mice
by: Yan-Jun Zhao, et al.
Published: (2016-09-01)